A novel imaging platform for non-invasive screening of abnormal glucose tolerance

Highlights • The prevalence of type 2 diabetes and prediabetes is increasing worldwide. • However, almost half of those affected are not aware of it. • The measurement of SAF was proposed as the noninvasive diagnosis of hyperglycemia. • We developed a novel imaging system with transmission geometry...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes research and clinical practice 2016-06, Vol.116, p.83-85
Main Authors: Jeong, Bosu, Jung, Chang Hee, Lee, Yong-ho, Shin, Il-hyung, Kim, Hansuk, Bae, Soo-Jin, Lee, Dae-Sic, Kang, Eun Seok, Kang, Uk, Kim, Jong Jin, Park, Joong-Yeol
Format: Article
Language:English
Subjects:
Adult
AGE
Aged
Diagnosis
Endocrinology & Metabolism
Female
Glucose intolerance
Glucose Intolerance - diagnostic imaging
Glycation End Products, Advanced - metabolism
Humans
Hyperglycemia - diagnostic imaging
Male
Mass Screening - methods
Middle Aged
Noninvasive
Optical Imaging - methods
Sensitivity and Specificity
Skin - metabolism
Skin auto-fluorescence
Spectrometry, Fluorescence - methods
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights • The prevalence of type 2 diabetes and prediabetes is increasing worldwide. • However, almost half of those affected are not aware of it. • The measurement of SAF was proposed as the noninvasive diagnosis of hyperglycemia. • We developed a novel imaging system with transmission geometry for SAF measurement. • It provides unique and comparable performance in screening for glucose intolerance.
ISSN:0168-8227
1872-8227
DOI:10.1016/j.diabres.2016.03.014